Completed

Effect of the Use of Endotracheal Tube With Subglottic Suction on Laryngospasm and Postoperative Complications in Rhinoplasty Operations

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Suction Above Cuff Endotracheal Tube

Other
Who is being recruted

Laryngeal Diseases+6

+ Laryngismus

+ Otorhinolaryngologic Diseases

From 18 to 65 Years
+12 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: June 2018
See protocol details

Summary

Principal SponsorYuzuncu Yil University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2018

Actual date on which the first participant was enrolled.

Suction Above Cuff Endotracheal Tube (SACETT) has a dorsal port above the cuff designed to allow continuous or intermittent suctioning of secretions from the subglottic space. Thus, it facilitates suctioning of excessive secretions around the mouth and the cuff. In this study, the investigators aimed to investigate the effect of the use of SACETT on laryngospasm and postoperative complications in rhinoplasty operations. This randomized controlled clinical trial was conducted in 132 patients undergoing rhinoplasty. The patients were randomly divided into 2 groups: Suction Above Cuff Endotracheal Tube (n:66) (Group SA) and classic endotracheal tube (n:66) (Group C). Complications following general anesthesia were statistically analyzed among the two groups. 55 male patients and 77 female patients were included in the study. The incidences of postoperative laryngospasm and respiratory complications were found to be lower in Group SA compared to Group C. In addition, the incidences of agitation, postoperative nausea and vomiting (PONV), swallowing difficulty, and sore throat were found to be lower in Group SA compared to Group C. However, the incidences of cough, hypotension, and tachycardia were similar in both groups. No PONV, swallowing difficulty, and hypotension were observed in Group SA. The blood volume accumulated in the suction chamber was found to be greater in Group SA compared to Group C. The investigators believe that the use of SACETT in rhinoplasty operations reduces the incidences of laryngospasm, emergence agitation, sore throat, swallowing difficulty, and PONV when compared with classic endotracheal tube.

Official TitleEffect of the Use of Endotracheal Tube With Subglottic Suction on Laryngospasm and Postoperative Complications in Rhinoplasty Operations
Principal SponsorYuzuncu Yil University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

132 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Laryngeal DiseasesLaryngismusOtorhinolaryngologic DiseasesPathologic ProcessesPostoperative ComplicationsRespiration DisordersRespiratory Tract DiseasesPathological Conditions, Signs and SymptomsVocal Cord Dysfunction

Criteria

3 inclusion criteria required to participate
Patients who will undergo rhinoplasty surgery,

American Society of Anesthesiologists (ASA) I-II patients,

Aged 18-65 years

9 exclusion criteria prevent from participating
Patients who had upper or lower respiratory tract infections,

asthma,

a history of allergy,

who received isoflurane and desflurane for maintenance of anesthesia,

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Group SA intubated with Suction Above Cuff Endotracheal Tube

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Van yuzuncu Yıl University, Dursun Odabas Medical Center

Van, Turkey (Türkiye)Open Van yuzuncu Yıl University, Dursun Odabas Medical Center in Google Maps
Suspended

Van yuzuncu Yıl University, Dursun Odabas Medical Center

Van, Turkey (Türkiye)
Completed2 Study Centers